Skip to main content

Table 4 Prevalence of HCV antibody and HCV RNA among Gorgan prison participants

From: A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting

  Total Residents New inmates People on OAT People with a history of OAT People with no history of OAT
Prevalence, n (%) n = 1892 n = 1482 n = 410 n = 621 n = 241 n = 949
HCV antibody 130 (6.9%) 111 (7.5%) 19 (4.6%) 71 (11.4%) 17 (7.1%) 38 (4.0%)
HCV RNA 90 (4.8%) 84 (5.7%) 6 (1.5%) 54 (8.7%) 10 (4.2%) 24 (2.5%)
  1. OAT opioid agonist therapy